Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart

J Clin Invest. 1998 Mar 15;101(6):1424-31. doi: 10.1172/JCI1012.

Abstract

Inhibitory G protein activity (Gi) and nitric oxide (NO) modulate muscarinic-cholinergic (MC) inhibition of cardiac beta-adrenergic inotropic responses. We hypothesized that Gi mediates MC-NO synthase (NOS) signal transduction. Isoproterenol (0.2-0.8 microg/min) and acetylcholine (1 microM) were administered to isolated perfused rat hearts pretreated with saline (controls; n = 8) or pertussis toxin (PT; 30 microg/kg intraperitoneally 3 d before study; n = 20). PT abrogated in vitro ADP-ribosylation of Gi protein alpha subunit(s) indicating near-total decrease in Gi protein function. Isoproterenol increased peak +dP/dt in both control (peak isoproterenol effect: +2, 589+/-293 mmHg/s, P < 0.0001) and PT hearts (+3,879+/-474 mmHg/s, P < 0.0001). Acetylcholine reversed isoproterenol inotropy in controls (108+/-21% reduction of +dP/dt response, P = 0.001), but had no effect in PT hearts. In controls, NG-monomethyl-L-arginine (100 microM) reduced basal +dP/dt, augmented isoproterenol +dP/dt (peak effect: +4,634+/-690 mmHg/s, P < 0.0001), and reduced the MC inhibitory effect to 69+/-8% (P < 0.03 vs. baseline). L-arginine (100 M) had no effect in controls but in PT hearts decreased basal +dP/dt by 1, 426+/-456 mmHg/s (P < 0.005), downward-shifted the isoproterenol concentration-effect curve, and produced a small MC inhibitory effect (27+/-4% reduction, P < 0.05). This enhanced response to NO substrate was associated with increased NOS III protein abundance, and a three- to fivefold increase in in vitro calcium-dependent NOS activity. Neomycin (1 microM) inhibition of phospholipase C did not reverse L-arginine enhancement of MC inhibitory effects. These data support a primary role for Gi in MC receptor signal transduction with NOS in rat heart, and demonstrate regulatory linkage between Gi and NOS III protein levels.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylcholine / metabolism
  • Acetylcholine / pharmacology
  • Adenosine Diphosphate / metabolism
  • Adrenergic beta-Agonists / metabolism
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Arginine / pharmacology
  • Calcium / metabolism
  • Enzyme Inhibitors / pharmacology
  • GTP-Binding Proteins / metabolism*
  • GTP-Binding Proteins / physiology
  • Heart / drug effects*
  • In Vitro Techniques
  • Isoproterenol / metabolism
  • Isoproterenol / pharmacology
  • Male
  • Myocardium / metabolism*
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Neomycin / pharmacology
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase / metabolism*
  • Pertussis Toxin*
  • Protein Synthesis Inhibitors / pharmacology
  • Proteins / metabolism*
  • Rats
  • Rats, Wistar
  • Receptors, Adrenergic, beta / metabolism
  • Receptors, Muscarinic / metabolism
  • Signal Transduction
  • Type C Phospholipases / antagonists & inhibitors
  • Virulence Factors, Bordetella / pharmacology*

Substances

  • Adrenergic beta-Agonists
  • Enzyme Inhibitors
  • Protein Synthesis Inhibitors
  • Proteins
  • Receptors, Adrenergic, beta
  • Receptors, Muscarinic
  • Virulence Factors, Bordetella
  • Nitric Oxide
  • Adenosine Diphosphate
  • Arginine
  • Nitric Oxide Synthase
  • Pertussis Toxin
  • Type C Phospholipases
  • GTP-Binding Proteins
  • Neomycin
  • Isoproterenol
  • Acetylcholine
  • Calcium
  • NG-Nitroarginine Methyl Ester